Pharma — September 2023
-
FDA Approves Pfizer-BioNTech's Updated COVID-19 Vaccine https://www.proinvestor.com/investornyt/1048339/fda-approves-pfizer-biontechs-updated-covid-19-vaccine
-
Moderna har succes med influenzavaccine https://www.proinvestor.com/investornyt/1049085/moderna-har-succes-med-influenzavaccine
-
Lundbeck fylder flere data på succesfuldt migrænestudie med ny kandidat https://www.proinvestor.com/investornyt/1049596/lundbeck-fylder-flere-data-pa-succesfuldt-migraenestudie-med-ny-kandidat
-
AstraZeneca Reports Positive Results From Phase III Trial With Datopotamab Deruxtecan https://www.proinvestor.com/investornyt/1053153/astrazeneca-reports-positive-results-from-phase-iii-trial-with-datopotamab-deruxtecan
-
Sanofi: Foreign Currency To Negatively Impact Q3 Sales, Business EPS - Quick Facts https://www.proinvestor.com/investornyt/1053160/sanofi-foreign-currency-to-negatively-impact-q3-sales-business-eps-quick-facts
-
Is Pfizer Stock a Buy Near 52-Week Lows for Its 5.08% Yield?
https://www.proinvestor.com/investornyt/1056178/is-pfizer-stock-a-buy-near-52-week-lows-for-its-508-yield
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind